KYNU and central nervous system cancer: Six genes of these essential TrMGs, including MAOB, HSD17B10, KYNU, AOX1, and OGDH, were determined as hazardous factors for glioma patients, and other two genes (CYP2E1 and ALDH2) were identified as protective factors (Figure 4B).